Raffaella Bucci , Lucia De Rosa , Gianmarco Bertoni , Rossella Di Stasi , Maria della Valle , Donatella Diana , Silvia Peppicelli , Kaliroi Peqini , Maria Luisa Gelmi , Francesca Bianchini , Luca Domenico D'Andrea
{"title":"Molecular and biological characterization of VEGF-mimetic peptidomimetic containing a morpholine β-amino acid","authors":"Raffaella Bucci , Lucia De Rosa , Gianmarco Bertoni , Rossella Di Stasi , Maria della Valle , Donatella Diana , Silvia Peppicelli , Kaliroi Peqini , Maria Luisa Gelmi , Francesca Bianchini , Luca Domenico D'Andrea","doi":"10.1016/j.bioorg.2025.109039","DOIUrl":null,"url":null,"abstract":"<div><div>The QK peptide is a 15-residue VEGF-mimetic compound known for its proangiogenic activity. Its helical conformation plays a crucial role in binding to VEGF receptors, activating intracellular signaling pathways in endothelial cells, promoting cell migration, proliferation, and survival. However, peptides composed exclusively by natural amino acids often suffer from poor stability in biological fluids, limiting their therapeutic potential. In this study, we modified the QK sequence shortening the peptide chain by incorporating a non-natural β-amino acid with a morpholine core, that promotes helical secondary structures in model peptides. Structural analysis using CD, FT-IR and NMR revealed that in water, MQK adopts a mixed conformation with partial helical content. Biological characterization on endothelial cells demonstrated that MQK peptidomimetic promotes cell proliferation, survival, migration and invasion providing strong evidence for its pro-angiogenic activity, and a reasonable protease resistance. In definitive, insertion of the morpholine β-amino acid partially destabilizes the helical structure and increases peptide flexibility relative to QK, without impairing biological function. This suggests that the enhanced conformational adaptability of MQK may favor adoption of the bioactive conformation and the interaction with the biological target.</div></div>","PeriodicalId":257,"journal":{"name":"Bioorganic Chemistry","volume":"165 ","pages":"Article 109039"},"PeriodicalIF":4.7000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioorganic Chemistry","FirstCategoryId":"92","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0045206825009198","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The QK peptide is a 15-residue VEGF-mimetic compound known for its proangiogenic activity. Its helical conformation plays a crucial role in binding to VEGF receptors, activating intracellular signaling pathways in endothelial cells, promoting cell migration, proliferation, and survival. However, peptides composed exclusively by natural amino acids often suffer from poor stability in biological fluids, limiting their therapeutic potential. In this study, we modified the QK sequence shortening the peptide chain by incorporating a non-natural β-amino acid with a morpholine core, that promotes helical secondary structures in model peptides. Structural analysis using CD, FT-IR and NMR revealed that in water, MQK adopts a mixed conformation with partial helical content. Biological characterization on endothelial cells demonstrated that MQK peptidomimetic promotes cell proliferation, survival, migration and invasion providing strong evidence for its pro-angiogenic activity, and a reasonable protease resistance. In definitive, insertion of the morpholine β-amino acid partially destabilizes the helical structure and increases peptide flexibility relative to QK, without impairing biological function. This suggests that the enhanced conformational adaptability of MQK may favor adoption of the bioactive conformation and the interaction with the biological target.
期刊介绍:
Bioorganic Chemistry publishes research that addresses biological questions at the molecular level, using organic chemistry and principles of physical organic chemistry. The scope of the journal covers a range of topics at the organic chemistry-biology interface, including: enzyme catalysis, biotransformation and enzyme inhibition; nucleic acids chemistry; medicinal chemistry; natural product chemistry, natural product synthesis and natural product biosynthesis; antimicrobial agents; lipid and peptide chemistry; biophysical chemistry; biological probes; bio-orthogonal chemistry and biomimetic chemistry.
For manuscripts dealing with synthetic bioactive compounds, the Journal requires that the molecular target of the compounds described must be known, and must be demonstrated experimentally in the manuscript. For studies involving natural products, if the molecular target is unknown, some data beyond simple cell-based toxicity studies to provide insight into the mechanism of action is required. Studies supported by molecular docking are welcome, but must be supported by experimental data. The Journal does not consider manuscripts that are purely theoretical or computational in nature.
The Journal publishes regular articles, short communications and reviews. Reviews are normally invited by Editors or Editorial Board members. Authors of unsolicited reviews should first contact an Editor or Editorial Board member to determine whether the proposed article is within the scope of the Journal.